Merck & Co Inc have also joined hands with five Indian generic drugmakers, including Cipla Ltd and Sun Pharmaceutical Industries Ltd, to expand production and access to its experimental COVID-19 drug. The partnership, according to Merck, will give the companies license to supply Merck's molnupiravir to India and more than 100 low- and middle-income countries following approvals or emergency authorization by local regulatory agencies.
Replicating the ‘war-room’ scenario has been Indian based
technology service providers like Accenture and Wipro. Their teams are working 13-14 hours daily, under growing pressure and struggling to deliver on projects as staff call in sick and take time off to care for friends and relatives.
Wipro said about 3% of its 197,000-odd employees are currently working from office on critical projects. Wipro said it has made living arrangements at the company's guest houses and hotels close to its offices.
Infosys, India's second largest software services firm, said it was operating remotely across all offices.
Tata Consultancy Services, India's top information technology (IT) services firm, similarly said its operations had not been affected. India's gigantic IT and call centre service industry employs more than 4.5 million people directly and relies substantially on thousands of graduates under the age of 30 to roll out services.